कंपनी का अवलोकन
PetMed Express, Inc. operates as a specialized pet pharmacy entity within the United States, focusing on the distribution of prescription and non-prescription medications, health products, and essential supplies for dogs, cats, and horses. The company functions within the broader Healthcare sector, specifically categorized under the industry of Pharmaceutical Retailers, which implies a business model centered on inventory management, regulatory compliance, and customer service for animal health needs. With a market capitalization of $49.65M, annual revenue of $186.96M, and an employee base of 173 individuals, the organization maintains a modest operational scale relative to large-cap retail peers. These valuation and revenue metrics suggest that the company occupies a niche position in the market, indicating it is a smaller-cap entity where financial performance is highly sensitive to changes in consumer demand for pet care products and the efficiency of its distribution network.
वित्तीय स्वास्थ्य
The financial statements for PetMed Express, Inc. reveal a revenue stream of $186.96M over the trailing twelve months, yet this generates a net income of $-64,869,000, highlighting a significant divergence that points to a cost structure burdened by high operating expenses or losses. The company reports an EBITDA of $-28,806,000, which serves as a critical indicator that operating cash flows are insufficient to cover the costs of goods sold and operational overheads effectively. Free cash flow stands at $-18,373,376, signaling a lack of financial flexibility that limits the company's ability to fund capital expenditures, repay debt, or pursue organic growth initiatives without external financing. The gross margin is recorded at 27.5%, suggesting that the company retains a reasonable portion of revenue after direct costs, but the operating margin of -25.7% and profit margin of -34.7% demonstrate that overhead costs and other expenses are eroding profitability significantly. In terms of liquidity and leverage, the company holds $26.91M in cash against $652,000 in debt, resulting in a debt-to-equity ratio of 1.99, which indicates a highly leveraged balance sheet relative to its equity base. However, the current ratio of 0.89 reveals that current assets are insufficient to cover current liabilities, pointing to potential short-term liquidity pressures. Furthermore, the return on equity is -100.6% and the return on assets is -20.3%, metrics that collectively reveal that management has not been effective in generating value for shareholders or utilizing the company's asset base to produce positive returns.
मूल्यांकन आकलन
Valuation metrics for PetMed Express, Inc. present a complex picture, as the trailing P/E ratio is listed as N/A due to the company's net losses, while the forward P/E stands at -77.33, implying that the market is pricing in continued earnings contraction or that traditional earnings-based valuation models are currently inapplicable. The price-to-book ratio is 1.51, indicating that the market is currently valuing the company at a premium of 51% above its tangible book value, which may reflect investor optimism regarding future regulatory changes or market share expansion despite current losses. Alternative valuation measures such as the price-to-sales ratio of 0.27 and the EV/EBITDA of -0.81 suggest that the stock is trading at a fraction of its sales revenue, which often occurs in distressed or turnaround scenarios where profitability has not yet been restored. The 52-week trading range spans from a low of $1.57 to a high of $4.32, and without a specific current share price provided in the available facts, the stock's position within this range cannot be precisely calculated, though the wide dispersion indicates high price volatility. The beta value of 0.78 suggests that the stock's price volatility is lower than the broader market, meaning it tends to move less aggressively than the overall index during periods of market fluctuation.
Growth & Income
Revenue growth year-over-year has declined by 21.7%, while earnings growth is N/A due to the absence of prior period profitability, indicating that the company is currently contracting in terms of top-line performance and has not yet achieved a path to earnings recovery. Since the company does not pay a dividend, as evidenced by a dividend yield of N/A and a payout ratio of 0.0%, it does not distribute any cash to shareholders, implying that all retained earnings are theoretically directed toward operational efforts, though the negative cash flow suggests a constraint on reinvestment capabilities. The overall growth and income profile for PetMed Express, Inc. is characterized by significant revenue contraction and a complete absence of dividend income, reflecting a business currently in a challenging financial phase where capital preservation is likely a priority over expansion or shareholder returns.